References
-
1
Pugh R N, Murray-Lyon I M, Dawson J L, Pietroni M C, Williams R.
Transection of the oesophagus for bleeding oesophageal varices.
Br J Surg.
1973;
60
646-649
-
2
Cooper G S, Bellamy P, Dawson N V, Desbiens N.
A prognostic model for patients with end-stage liver disease.
Gastroenterology.
1997;
113
1278-1288
-
3
Knaus W A, Draper E A, Wagner D P, Zimmerman J E.
APACHE II: a severity of disease classification system.
Crit Care Med.
1985;
13
818-829
-
4
Sudlow G, Birkett D J, Wade D N.
Further characterization of specific drug binding sites on human serum albumin.
Mol Pharmacol.
1976;
12
1052-1061
-
5
Sudlow G, Birkett D J, Wade D N.
The characterization of two specific drug binding sites on human serum albumin.
Mol Pharmacol.
1975;
11
824-832
-
6
Carter D C, Ho J X.
Structure of serum albumin.
Adv Protein Chem.
1994;
45
153-203
-
7
Fehske K J, Müller W E, Wollert U.
Commentary The Location Of Drug Binding Sites In Human Serum Albumin.
Biochem Pharmacol.
1981;
30
687-692
-
8
Kragh-Hansen U.
Structure and ligand binding properties of human serum albumin.
Dan Med Bull.
1990;
37
57-84
-
9 Peters T. All about albumin. San Diego, Ca; Academic Press Inc 1996
-
10
Peters Jr T.
Serum albumin.
Adv Protein Chem.
1985;
37
161-245
-
11 Brodersen R. Binding of Bilirubin and other ligands to human serum albumin. Peters T and Sjöholm I Albumin: Structure, Biosynthesis and Function Pergamon Press 1977: 61-70.
-
12
Banagale R C, Bernstein L H.
Reserve bilirubin binding capacity measured by absorbance deviation at saturation of primary albumin binding sites.
Res Commun Chem Pathol Pharmacol.
1982;
38
463-479
-
13
Burckart G J, Whitington P F, Gross S R.
Reserve bilirubin binding capacity determined by difference spectroscopy. i. modifications and performance of the difference spectroscopy assay.
J Pediatr Gastroenterol Nutr.
1982;
1
489-493
-
14
Whitington P F, Burckart G J, Gross S R, Korones S B, Helms R A.
Alterations in reserve bilirubin binding capacity of albumin by free fatty acids. ii. in vitro and in vivo studies using difference spectroscopy.
J Pediatr Gastroenterol Nutr.
1982;
1
495-501
-
15
Kragh-Hansen U.
Octanoate binding to the indole - and benzodiazepine binding region of human serum albumin.
Biochem J.
1991;
273
641-644
(S 02)
-
16
Brodersen R, Hansen P.
Bilirubin displacing effect of stabilizers added to injectable preparations of human serum albumin.
Acta Paediatr Scand.
1977;
66
133-135
-
17
Ebbesen F, Brodersen R.
Comparison between two preparations of human serum albumin in treatment of neonatal hyperbilirubinaemia.
Acta Paediatr Scand.
1982;
71
85-90
Sebastian Klammt
Rostock
Email: sebastian.klammt@medizin.uni-rostock.de
